Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,805 | 29,117 | 3,870 | 18,790 | 15,260 |
| Marketable Securities | 224,874 | 219,269 | 251,434 | 244,212 | 253,901 |
| TOTAL | $249,863 | $256,104 | $263,134 | $270,618 | $276,446 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 276 | 398 | 489 | 580 | 658 |
| TOTAL | $276 | $398 | $489 | $580 | $658 |
| Total Assets | $250,139 | $256,502 | $263,623 | $271,198 | $277,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,848 | 3,988 | 2,756 | 3,209 | 3,098 |
| TOTAL | $12,916 | $12,129 | $9,715 | $9,053 | $8,542 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 29 | 115 | 198 | 279 |
| TOTAL | $N/A | $29 | $115 | $198 | $279 |
| Total Liabilities | $12,916 | $12,158 | $9,830 | $9,251 | $8,821 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,100 | 74,133 | 72,952 | 72,758 | 72,596 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -182,202 | -168,192 | -157,244 | -147,956 | -138,384 |
| Other shareholders' equity | -104 | -54 | -46 | 333 | -812 |
| TOTAL | $237,223 | $244,344 | $253,793 | $261,947 | $268,283 |
| Total Liabilities And Equity | $250,139 | $256,502 | $263,623 | $271,198 | $277,104 |